BeGraft Aortic Stent for Treatment of Aortic Coarctation: Acute and Intermediate Results
Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1877-1883
DOI: 10.1002/ccd.70551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 10.03.2026. Verfasst von Yuval Barak-Corren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pediatric Cardiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Aortic Coarctation, Stents, Angioplasty, Balloon, Endovascular Procedures. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Covered stent implantation is an effective treatment for coarctation of the aorta (CoA) and can reduce aortic wall injury; however, stent‐related complications, including recoil, restenosis, infolding, and access site injury, are of concern.
Aims
Report our institutional experience using the BeGraft Aortic covered stent for native and recurrent CoA.
Methods
Retrospective review of consecutive patients treated for CoA from January 2017 to April 2025 [IRB RMC 389‐22].
Results
Eighty‐five patients [61 male], median age 14.1 years, median weight 50 kg, underwent implantation of 92 BeGraft Aortic stents, 71 (84%) through a 9 Fr sheath. CoA diameter increased by 170% (IQR 150%–270%) and pressure gradient decreased by 16 mmHg (IQR 10–23 mmHg) to a median of 4 mmHg (IQR 0–6 mmHg). Final stent‐to‐balloon diameter ratio was 0.94 ± 0.05 (5.6% recoil, IQR 2.8%–9.4%). During median follow‐up of 2.7 years (IQR 1.0–4.3 years, max 7.3 years), 38 patients underwent re‐imaging (CT, angiography), which demonstrated two new aneurysms. Eight aneurysms present prior to BeGraft aortic implantation completely resolved, and one patient had an asymptomatic femoral artery occlusion. Of the 24 patients who underwent additional catheterizations, 19 had re‐interventions, 13 balloon dilations, and 6 stent implantations: 10 restenosis, 7 somatic growth, and 2 aneurysms.
Conclusions
In this single‐center experience, BeGraft Aortic covered stents were associated with favorable technical results, including minimal stent recoil and low rates of reintervention for restenosis or aneurysm formation. The low‐profile delivery system affords treatment of CoA for smaller children with low risk for vascular damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Pediatric Cardiology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
ORCID-Profile: Gabriel Amir
Zitieren
APA
Barak-Corren, Y., Fried, E., Dagan, T., Steiner, K., Amir, G., Birk, E., & Bruckheimer, E. (2026). BeGraft Aortic Stent for Treatment of Aortic Coarctation: Acute and Intermediate Results. Catheterization and Cardiovascular Interventions, 107(6), 1877-1883. https://doi.org/10.1002/ccd.70551
Vancouver
Barak-Corren Y, Fried E, Dagan T, Steiner K, Amir G, Birk E, et al. BeGraft Aortic Stent for Treatment of Aortic Coarctation: Acute and Intermediate Results. Catheterization and Cardiovascular Interventions. 2026;107(6):1877-1883. doi:10.1002/ccd.70551
BibTeX
@article{BarakCorren2026,
author = {Barak-Corren, Yuval and Fried, Eli and Dagan, Tamir and Steiner, Kristoffer and Amir, Gabriel and Birk, Einat and Bruckheimer, Elchanan},
title = {BeGraft Aortic Stent for Treatment of Aortic Coarctation: Acute and Intermediate Results},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {107},
number = {6},
pages = {1877--1883},
doi = {10.1002/ccd.70551}
}
EUVIMED